New University of Virginia School of Medicine research revealing the fingerprints of Sudden Infant Death Syndrome within ...

Scorpius announced its collaboration with KaloCyte. Under this initial project, Scorpius will utilize its scientific and technical expertise to ...

Rigel Pharmaceuticals (RIGL) announced the first patient has been enrolled in a Phase 1 study evaluating the safety and tolerability of ...